| Efficacy and Safety Study of MYOBLOC in the Treatment of Sialorrhea in Pediatric Subjects (NCT05097079) | Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC | 2021-11-01 |
| Botulinum Toxin Injection for Sialorrhea in Cerebral Palsy (NCT06101160) | Cairo University | 2021-06-30 |
| Double-blind, Placebo-controlled, Randomized Clinical Trial Comparing the Efficacy and Safety of Sialanar Plus orAl rehabiLitation Against Placebo Plus Oral Rehabilitation for chIldren and Adolescents With seVere Sialorrhoea and Neurodisabilties, (NCT04873115) | Proveca Pharma Limited | 2021-05-10 |
| Safety and Efficacy of Cryoablation in Management of Sialorrhea in Patients With Neurological Disorders (NCT03704168) | Dean Nakamoto | 2019-05-01 |
| Ipratropium Bromide Spray as Treatment for Sialorrhea in Children (NCT03747536) | London Health Sciences Centre | 2019-01-01 |
| Prevalence of Sialorrhea in Patients Treated With Clozapine (NCT04197037) | Parc de Salut Mar | 2018-03-20 |
| Study of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's Disease (NCT02382198) | Ottawa Hospital Research Institute | 2016-07-01 |
| Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adults (NCT02610868) | Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC | 2015-10-01 |
| Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult Subjects (NCT01994109) | Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC | 2013-11-01 |
| Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism (NCT01653132) | Beth Israel Deaconess Medical Center | 2012-03-01 |
| Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea (NCT01551940) | Hospices Civils de Lyon | 2012-02-01 |
| Application of Botulinum Toxin Type A in Salivary Glands in the Treatment of Drooling in Patients With Cerebral Palsy (NCT01489904) | Hospital Vall d'Hebron | 2011-11-01 |
| Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine Sedation (NCT01191398) | Craig J. Huang | 2010-06-01 |
| Oral Health Literacy Tailored Communication (NCT01118143) | University of Tromso | 2010-06-01 |
| Botulinum Toxin-A for Sialorrhoea Treatment in Asian Adults With Neurological Diseases (NCT02425176) | University of Malaya | 2009-09-01 |
| Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions (NCT00491894) | Shionogi | 2007-03-01 |
| Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT00125203) | The University of Texas Health Science Center at San Antonio | 2003-07-01 |
| FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey (NCT00683891) | Azur Pharma, Inc | |